Researcher | Research Overview
Dr. Whangbo’s research aims to understand how factors influencing immune reconstitution following allogeneic hematopoietic stem cell transplantation (HSCT) contribute to clinical outcomes such as graft failure, disease relapse, and graft-versus-host disease (GVHD). In addition, Dr. Whangbo’s clinical research focuses on initiating new clinical trials to evaluate novel approaches for the prevention and treatment of chronic GVHD in children.
Researcher | Research Background
Dr. Whangbo received her PhD from the University of California-San Francisco and her medical degree from the University of California-Los Angeles. She completed her pediatric residency in the Boston Combined Residency Program and then completed a Pediatric Hematology-Oncology fellowship at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.